Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma

NCT03927222 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Resource shortage

Conditions

Glioblastoma

Interventions

BIOLOGICAL: Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
DRUG: Temozolomide
BIOLOGICAL: Tetanus-Diphtheria Toxoid (Td)
BIOLOGICAL: GM-CSF
BIOLOGICAL: 111-Indium-labeling of Cells for in vivo Trafficking Studies

Sponsor

Mustafa Khasraw, MBChB, MD, FRCP, FRACP